Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo

doi:10.3748/wjg.v22.i32.7342

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8130)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

586

WORD

408

HTML

4143

Figures (1-2)

226

Tables (1-5)

151

Sum=5514

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

873

Download

1743

Sum=2616

Aug 28, 2016 (publication date) through May 22, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Aug 28, 2016; 22(32): 7342-7352
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7342

Table 1 Tumor apoptosis ratios in experimental groups and control group (mean ± SD)

Group	24 h	48 h	72 h	120 h	168 h
Control	0.25 ± 0.02	0.28 ± 0.01	0.27 ± 0.02	0.29 ± 0.02	0.24 ± 0.04
5-FU	0.27 ± 0.03	0.31 ± 0.03	0.31 ± 0.05	0.30 ± 0.04	0.31 ± 0.02
rAd-p53	0.29 ± 0.02	0.35 ± 0.03	0.43 ± 0.08	0.42 ± 0.06	0.46 ± 0.06
5-FU + rAd-p53	0.33 ± 0.03	0.44 ± 0.08	0.58 ± 0.07	0.59 ± 0.05	0.62 ± 0.07
F	13.235	41.487	53.812	61.676	80.755
P value	0	0	0	0	0
P value	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
5-FU vs Control	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs Control	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs Control	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs rAd-p53	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs 5-FU	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	>0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs 5-FU	>0.05	< 0.05	< 0.05	< 0.05	< 0.05

Table 2 Relative IOD of p53 expression in experimental groups and control group (mean ± SD)

Group	24 h	48 h	72 h	120 h	168 h
Control	0.099 ± 0.001	0.105 ± 0.003	0.101 ± 0.007	0.105 ± 0.015	0.103 ± 0.001
5-FU	0.108 ± 0.002	0.098 ± 0.028	0.096 ± 0.004	0.097 ± 0.047	0.096 ± 0.033
rAd-p53	0.187 ± 0.003	0.209 ± 0.014	0.627 ± 0.005	0.743 ± 0.012	0.713 ± 0.005
5-FU + rAd-p53	0.393 ± 0.004	0.461 ± 0.002	0.691 ± 0.018	0.822 ± 0.009	0.808 ± 0.027
F	221.565	270.392	3983.173	9639.595	3867.703
P value	0	0	0	0	0
P value	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
5-FU vs Control	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs Control	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs Control	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs rAd-p53	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs 5-FU	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs 5-FU	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05

Table 3 Relative IOD of protein kinase C expression in experimental groups and control group (mean ± SD)

Group	24 h	48 h	72 h	120 h	168 h
Control	1.13 ± 0.08	1.21 ± 0.06	0.99 ± 0.13	1.26 ± 0.42	1.08 ± 0.20
5-FU	0.94 ± 0.21	1.12 ± 0.14	0.93 ± 0.14	1.08 ± 0.52	1.04 ± 0.26
rAd-p53	0.93 ± 0.42	0.91 ± 0.23	1.07 ± 0.13	0.57 ± 0.18	0.36 ± 0.09
5-FU + rAd-p53	1.23 ± 0.24	0.53 ± 0.09	0.45 ± 0.10	0.26 ± 0.06	0.08 ± 0.01
F	1.036	33.972	14.348	24.072	71.559
P value	0.427	0	0.01	0	0
P value	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
5-FU vs Control	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
P value	> 0.05	< 0.05	> 0.05	< 0.05	< 0.05
rAd-p53 vs Control	> 0.05	< 0.05	> 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd/p53 + 5- FU vs Control	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs rAd-p53	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs 5-FU	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	> 0.05	< 0.05	< 0.05
rAd-p53 vs 5-FU	> 0.05	< 0.05	> 0.05	< 0.05	< 0.05

Table 4 Relative IOD of P-gp expression in experimental groups and control group (mean ± SD)

Group	24 h	48 h	72 h	120 h	168 h
Control	1.28 ± 0.20	1.32 ± 0.31	1.36 ± 0.40	1.29 ± 0.43	1.30 ± 0.56
5-FU	1.17 ± 0.37	1.13 ± 0.41	1.17 ± 0.39	1.27 ± 0.47	1.29 ± 0.56
rAd-p53	1.12 ± 0.31	0.69 ± 0.11	0.62 ± 0.02	0.36 ± 0.15	0.26 ± 0.06
5-FU + rAd-p53	0.86 ± 0.17	0.65 ± 0.21	0.59 ± 0.25	0.31 ± 0.01	0.10 ± 0.03
F	5.670	7.301	14.645	9.844	7.971
P value	0.022	0.011	0.001	0.005	0.009
P value	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
5-FU vs Control	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs Control	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs Control	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	> 0.05	> 0.05	> 0.05	> 0.05
rAd-p53 + 5-FU vs rAd-p53	< 0.05	> 0.05	> 0.05	> 0.05	> 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs 5-FU	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs 5-FU	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05

Table 5 Relative IOD of MRP1 expression in experimental groups and control group (mean ± SD)

Group	24 h	48 h	72 h	120 h	168 h
Control	1.31 ± 0.36	1.33 ± 0.08	1.09 ± 0.24	1.22 ± 0.35	1.07 ± 0.22
5-FU	1.27 ± 0.10	1.31 ± 0.11	1.14 ± 0.16	1.20 ± 0.31	1.13 ± 0.14
rAd-p53	0.98 ± 0.09	0.74 ± 0.11	0.58 ± 0.18	0.87 ± 0.31	0.31 ± 0.08
5-FU + rAd-p53	0.71 ± 0.17	0.62 ± 0.02	0.51 ± 0.10	0.42 ± 0.08	0.13 ± 0.10
F	6.438	123.754	20.567	15.512	36.073
P value	0.016	0	0	0.001	0
P value	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
5-FU vs Control	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs Control	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs Control	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	> 0.05	< 0.05	> 0.05
rAd-p53 + 5-FU vs rAd-p53	> 0.05	< 0.05	> 0.05	< 0.05	> 0.05
P value	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 + 5-FU vs 5-FU	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05
P value	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05
rAd-p53 vs 5-FU	> 0.05	< 0.05	< 0.05	< 0.05	< 0.05

Citation: Xie Q, Wu MY, Zhang DX, Yang YM, Wang BS, Zhang J, Xu J, Zhong WD, Hu JN. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo. World J Gastroenterol 2016; 22(32): 7342-7352
URL: https://www.wjgnet.com/1007-9327/full/v22/i32/7342.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i32.7342